Quadrant Capital Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
Quadrant Capital Group's LMAT Position: Q3 2026 in Review
Quadrant Capital Group reduced its LeMaitre Vascular (LMAT) stake by 9.6% in Q3 2026, selling an estimated $36.8K and leaving 3,915 shares worth $319K. The position accounts for 0.01% of the portfolio, ranked #1047.
Quadrant Capital Group first reported a position in LMAT in Q1 2020 and has held it in 27 quarters since. The position peaked at $474K in Q1 2026. 62 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.
- Quadrant Capital Group held 3,915 shares of LeMaitre Vascular worth $319K as of Q3 2026.
- Quadrant Capital Group sold 415 LeMaitre Vascular shares in Q3 2026, an estimated $36.8K.
- LeMaitre Vascular made up 0.01% of Quadrant Capital Group's portfolio in Q3 2026, its #1047 holding.
- Quadrant Capital Group first reported a position in LeMaitre Vascular in Q1 2020 and has held it in 27 quarters since.
- Quadrant Capital Group's LeMaitre Vascular position peaked at $474K in Q1 2026.
- 62 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.
Based on Quadrant Capital Group's 13F filing for Q3 2026, filed 20 Oct 2026.